PARD (Poniard Pharmaceuticals) Receivables Turnover: 0.00 (As of Sep. 2011)


What is Poniard Pharmaceuticals Receivables Turnover?

Poniard Pharmaceuticals PARD Receivables Turnover is 0.00 as of Sep. 2011.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Poniard Pharmaceuticals's Revenue for the three months ended in Sep. 2011 was $0.00 Mil. Poniard Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2011 was $0.00 Mil.

Poniard Pharmaceuticals  (OTCPK:PARD) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Poniard Pharmaceuticals Receivables Turnover Related Terms

Poniard Pharmaceuticals Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Receivables Turnover Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PARD vs OBMP, NSPX, ATRX: Receivables Turnover Comparison

For the Biotechnology subindustry, Poniard Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Receivables Turnover falls into.


Poniard Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Poniard Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Dec. 2010 is calculated as

Receivables Turnover (A: Dec. 2010 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2010 ) / ((Accounts Receivable (A: Dec. 2009 ) + Accounts Receivable (A: Dec. 2010 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

Poniard Pharmaceuticals's Receivables Turnover for the quarter that ended in Sep. 2011 is calculated as

Receivables Turnover (Q: Sep. 2011 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Sep. 2011 ) / ((Accounts Receivable (Q: Jun. 2011 ) + Accounts Receivable (Q: Sep. 2011 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
Poniard Pharmaceuticals (PARD) has a Receivables Turnover of 0.00 as of Sep. 2011. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Receivables Turnover too high?
Poniard Pharmaceuticals' current Receivables Turnover is 0.00.
How does Poniard Pharmaceuticals' Receivables Turnover compare to OBMP and NSPX?
Poniard Pharmaceuticals' Receivables Turnover of 0.00 can be compared against companies in the Biotechnology industry. The industry median Receivables Turnover is 5.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.27, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Poniard Pharmaceuticals and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poniard Pharmaceuticals's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Receivables Turnover is 0.00 as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.